Mr Christopher Ogden, Consultant Urologist

Mr Christopher Ogden

Consultant Urologist

Mr Christopher Ogden MB BS MS FRCSEd FRCSEng FRCSUrol FEBU

Consultant Urologist

MB BS MS FRCSEd FRCSEng FRCSUrol FEBU

Mr Christopher Ogden

Consultant Urologist MB BS MS FRCSEd FRCSEng FRCSUrol FEBU

MB BS MS FRCSEd FRCSEng FRCSUrol FEBU
MrChristopher Ogden,Urologist
Mr Christopher Ogden - BBC Radio 5 - Live Health Magazine Programme
Barefoot Surgery - Horizon: Defeating Cancer
BBC interview - Mr Christopher Ogden - Radical robotic prostatectomy
A breakthrough UTI treatment
Catheter Problems
Current UTI treatments

Areas of expertise

  • Prostate cancer
  • Robotic prostatectomy
  • Focal HIFU therapy for prostate cancer
  • Transperineal laser ablation (TPLA) for benign and cancerous lesions of the prostate
  • Benign prostatic hyperplasia (BPH)

Recommendations for Mr Ogden

These recommendations are for information purposes only. Doctors providing recommendations do so in good faith and are not responsible for clinical outcomes.

Recommended by:

  • byMr Paul Cathcart, Urological Surgeon

    ❝Mr Christopher Ogden is a top prostate cancer specialist with extensive operative experience.❞

  • byProf. Mark Emberton, Professor of Urology

    ❝Mr Christopher Ogden is probably the best prostate cancer specialist in the UK.❞

  • byMr Dan Wood, Consultant Urologist

    ❝Recommended Urologist❞

  • by Mr Hashim Uddin Ahmed, Urologist

    ❝Recommended Urologist❞

  • Mr Ken Anson, Mr Anson has now retired from his HCA practice

    by Mr Ken Anson, Mr Anson has now retired from his HCA practice

    ❝Recommended Urologist❞

  • byMr Paul Cathcart, Urological Surgeon

    ❝Mr Christopher Ogden is a top prostate cancer specialist with extensive operative experience.❞

  • byProf. Mark Emberton, Professor of Urology

    ❝Mr Christopher Ogden is probably the best prostate cancer specialist in the UK.❞

  • byMr Dan Wood, Consultant Urologist

    ❝Recommended Urologist❞

  • by Mr Hashim Uddin Ahmed, Urologist

    ❝Recommended Urologist❞

  • Mr Ken Anson, Mr Anson has now retired from his HCA practice

    by Mr Ken Anson, Mr Anson has now retired from his HCA practice

    ❝Recommended Urologist❞

  • Address

    About Mr Christopher Ogden

    GMC number: 2957661

    Year qualified: 1984

    Place of primary qualification: University of London

    Initial consultation fee: £330

    Follow up consultation fee: £230

    Mr Christopher Ogden is a renowned consultant uro-oncologist at The Harley Street Clinic and The Princess Grace Hospital, both part of HCA Healthcare UK. He is celebrated for his pioneering work in robotic surgery, having performed the first private robotic surgery in the UK. Since then, he has conducted thousands of robotically assisted procedures, establishing himself as a high-volume, experienced surgeon.

    Mr Ogden's expertise extends to transperineal laser ablation (TPLA) of the prostate, a micro-invasive treatment offering excellent outcomes with minimal risk. He was the first consultant in the UK to perform this procedure and remains one of the few globally proficient in it. His work in TPLA was presented at the BAUS international congress in 2023, showcasing significant patient benefits and no complications.

    In collaboration with Dr Jihad Kaouk from the Cleveland Clinic, Mr Ogden performed Europe’s first radical robotic perineal prostatectomy. This innovative approach has been developed in partnership with the NHS and reviewed positively at University College London Hospitals.

    Mr Ogden was also among the first to use high intensity focused ultrasound (HIFU) for prostate cancer treatment. He has compared whole gland HIFU with robotic surgery and co-authored a paper on focal HIFU outcomes, published in the Journal of Urology.

    A respected trainer in minimally invasive procedures, Mr Ogden continues to advance the field through research and education. He has presented numerous papers on TPLA and transperineal robot-assisted radical prostatectomy using the DaVinci Xi surgical system. His dedication to improving patient care and surgical outcomes makes him a leading figure in uro-oncology.

    Areas of expertise

    • Benign prostatic hyperplasia (BPH)
    • Bladder cancer
    • Bladder instillation
    • Bladder pain
    • Blood in urine (haematuria)
    • Circumcision
    • Cystoscopy
    • Epididymal cysts
    • Focal therapy for prostate cancer
    • High-intensity focused ultrasound (HIFU)
    • Kidney stone prevention
    • Kidney stones
    • MRI of prostate
    • Nerve-sparing prostatectomy
    • Orchidectomy
    • Prostate biopsy
    • Prostate cancer
    • Prostate cancer diagnostics
    • Prostatectomy (radical)
    • Prostatectomy (robotic)
    • Prostatectomy (TURP)
    • Prostatitis (prostate swelling)
    • PSA testing
    • Retzius-sparing radical prostatectomy
    • Robotic surgery
    • Testicular pain
    • Transperineal laser ablation (TPLA)
    • Transrectal ultrasound (TRUS)
    • Transurethral resection of a bladder tumour (TURBT)
    • Urethral and bladder neck sparing in prostatectomy
    • Urinary incontinence
    • Urinary retention
    • Urinary tract infections (UTIs)
    • Urological (genitourinary) cancers
    • Varicocele
    • Vasectomy (male sterilisation)

    Professional memberships

    European Association of Urology
    Royal College of Surgeons of England
    British Medical Association (BMA)
    Royal Society of Medicine
    Medical Defence Union
    General Medical Council

    Articles by Mr Christopher Ogden

    Transperineal Laser Ablation (TPLA) of the prostate

    Transperineal robot-assisted radical prostatectomy using the DaVinci Xi surgical system

    Cancer control outcomes following focal therapy using high-intensity focused ultrasound in 1379 men with nonmetastatic prostate cancer

    Focal therapy compared to radical prostatectomy for non-metastatic prostate cancer

    An exploratory study of dose escalation versus standard focal high intensity focused ultrasound for treating non-metastatic prostate cancer

    Evaluation of functional outcomes following a second focal-HIFU in men with primary localised, non-metastatic prostate cancer; results from the high intensity focused ultrasound evaluation and assessment of treatment (heat) registry

    Supplementary material

    A multicentre study of 5-year outcomes following focal therapy in treating clinically significant nonmetastatic prostate cancer

    Mp30-11 predictors of poor functional outcomes after focal high intensity focussed ultrasound (HIFU)

    Focal therapies in prostate cancer

    Robotic assisted perineal prostatectomy